Celgene could pay up to $500mm in option deal with Inhibrx; value later revealed at $934.1mm
- Large Molecule
- Intra-Biotech Deal
- Includes Contract
- R+D and Marketing-Licensing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.